By modulating the HSPome, HSP90 inhibitors affect complex intracellular networks involved in the development of pulmonary fibrosis and offer strong rationale as useful therapeutical interventions directing cells through protein degradation. The gene discussed is HSP90AA1; the disease is pulmonary fibrosis.